Staging and neuroprogression in bipolar disorder (Q38054585)

27 August 2017

Staging and neuroprogression in bipolar disorder (English)

1 reference

27 August 2017

1 reference

Maurício Kunz

6

0 references

Laura Stertz

object named as

Laura Stertz

3

0 references

Gabriel R. Fries

object named as

Gabriel Rodrigo Fries

1

0 references

Flávio Kapczinski

7

object named as

Flávio Kapczinski

1 reference

27 August 2017

2

Bianca Pfaffenseller

1 reference

27 August 2017

André Vinicius Contri Paz

4

1 reference

27 August 2017

Aroldo Ayub Dargél

5

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Current Psychiatry Reports

27 August 2017

1 reference

27 August 2017

14

1 reference

27 August 2017

6

1 reference

27 August 2017

667-675

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-012-0319-2

27 August 2017

0 references

cites work

Neurobiological correlates of illness progression in the recurrent affective disorders

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Allostatic load in bipolar disorder: implications for pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Predictors of recurrence in affective disorder. A case register study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Staging bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The clinical implications of cognitive impairment and allostatic load in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The concept of allostasis in biology and biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Regional cerebral cortical thinning in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Regional prefrontal gray and white matter abnormalities in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Reduced left anterior cingulate volumes in untreated bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Reduction of cingulate gray matter density in poor outcome bipolar illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Evidence and implications for early intervention in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Basal ganglia shape alterations in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Brain magnetic resonance imaging of structural abnormalities in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Corpus callosum areas in first-episode patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Progressive gray matter loss in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Illness duration and total brain gray matter in bipolar disorder: evidence for neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Cell pathology in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Dynamic regulation of mitochondrial function by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Hypothalamic-pituitary-adrenal axis and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Increased serum neurotrophin-4/5 levels in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Peripheral biomarkers and illness activity in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The role of BDNF as a mediator of neuroplasticity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Biomarkers in cancer staging, prognosis and treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Increased plasma levels of brain-derived neurotrophic factor in patients with long-term bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Chemokines in bipolar disorder: trait or state?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Free radicals and antioxidants: updating a personal view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Oxidative stress markers in bipolar disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The potential utility of a staging model as a course specifier: a bipolar disorder perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Clinical implications of a staging model for bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

The impact of staging bipolar disorder on treatment outcome of family psychoeducation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Misdiagnosed Patients With Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Hippocampal volumes in adults with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-012-0319-2

Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.

21 January 2018

1 reference

12 December 2020

Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder.

1 reference

12 December 2020

Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder

1 reference

12 December 2020

The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia

1 reference

12 December 2020

Clinical staging: a heuristic model for psychiatry and youth mental health.

1 reference

12 December 2020

Impaired mitochondrial function in psychiatric disorders

1 reference

12 December 2020

Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs

1 reference

12 December 2020

Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors.

1 reference

12 December 2020

Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance

1 reference

12 December 2020

Corpus callosum signal intensity in patients with bipolar and unipolar disorder

1 reference

12 December 2020

Oxidative imbalance in bipolar disorder subtypes: a comparative study

1 reference

12 December 2020

Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania

1 reference

12 December 2020

MRI analysis of cerebellar vermal abnormalities in bipolar disorder

1 reference

12 December 2020

The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH.

1 reference

12 December 2020

3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder

1 reference

12 December 2020

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder

1 reference

12 December 2020

Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study

1 reference

12 December 2020

Neuroprotective effects of antidepressant and mood stabilizing drugs

1 reference

12 December 2020

10.1007/S11920-012-0319-2

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference